540 related articles for article (PubMed ID: 11833860)
21. Criteria for gauging response to sodium oxybate for narcolepsy.
Steffen AD; Lai C; Weaver TE
J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601
[TBL] [Abstract][Full Text] [Related]
22. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Black J; Swick T; Bogan R; Lai C; Carter LP
Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
[TBL] [Abstract][Full Text] [Related]
23. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
24. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Dauvilliers Y; Šonka K; Bogan RK; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Chen A; Black J; Skobieranda F; Thorpy MJ
CNS Drugs; 2022 Jun; 36(6):633-647. PubMed ID: 35635687
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
[TBL] [Abstract][Full Text] [Related]
26. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
Mamelak M; Black J; Montplaisir J; Ristanovic R
Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
[TBL] [Abstract][Full Text] [Related]
27. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
[TBL] [Abstract][Full Text] [Related]
28. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy.
Roth T; Dauvilliers Y; Guinta D; Alvarez-Horine S; Dynin E; Black J
J Sleep Res; 2017 Aug; 26(4):407-414. PubMed ID: 27807903
[TBL] [Abstract][Full Text] [Related]
29. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Bogan RK; Roth T; Schwartz J; Miloslavsky M
J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
[TBL] [Abstract][Full Text] [Related]
30. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
Borgen LA; Okerholm RA; Lai A; Scharf MB
J Clin Pharmacol; 2004 Mar; 44(3):253-7. PubMed ID: 14973300
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy.
Bogan RK; Thorpy MJ; Dauvilliers Y; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Tang L; Skobieranda F; Šonka K
Sleep; 2021 Mar; 44(3):. PubMed ID: 33184650
[TBL] [Abstract][Full Text] [Related]
32. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
[TBL] [Abstract][Full Text] [Related]
34. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
Mamelak M; Swick T; Emsellem H; Montplaisir J; Lai C; Black J
Sleep Med; 2015 Jan; 16(1):52-8. PubMed ID: 25533539
[TBL] [Abstract][Full Text] [Related]
35. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida CA; Shapiro CM; Roth T; Thorpy MJ; Corser BC; Ajayi AO; Rosenberg R; Roy A; Seiden D; Dubow J; Dauvilliers Y
Sleep; 2022 Jun; 45(6):. PubMed ID: 34358324
[TBL] [Abstract][Full Text] [Related]
36. Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience.
Poryazova R; Tartarotti S; Khatami R; Baumann CR; Valko P; Kallweit U; Werth E; Bassetti CL
Eur Neurol; 2011; 65(3):175-82. PubMed ID: 21389728
[TBL] [Abstract][Full Text] [Related]
37. Ritanserin improves sleep quality in narcolepsy.
Mayer G
Pharmacopsychiatry; 2003 Jul; 36(4):150-5. PubMed ID: 12905101
[TBL] [Abstract][Full Text] [Related]
38. Weight loss in narcolepsy patients treated with sodium oxybate.
Husain AM; Ristanovic RK; Bogan RK
Sleep Med; 2009 Jun; 10(6):661-3. PubMed ID: 19014899
[TBL] [Abstract][Full Text] [Related]
39. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
Lecendreux M; Plazzi G; Dauvilliers Y; Rosen CL; Ruoff C; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
J Clin Sleep Med; 2022 Sep; 18(9):2217-2227. PubMed ID: 35689598
[TBL] [Abstract][Full Text] [Related]
40. The use of sodium oxybate to treat narcolepsy.
Mayer G
Expert Rev Neurother; 2012 May; 12(5):519-29. PubMed ID: 22550980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]